Newsroom
Sorted by: Latest
-
State Street Corporation Declares Dividends on Its Non-Cumulative Perpetual Preferred Stock Series “G,” “I,” “J,” “K,” and “L”
BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE:STT) today announced a cash dividend on each of the below outstanding series of non-cumulative perpetual preferred stock: Series G (represented by depositary shares, each representing a 1/4000th interest in a share of Series G preferred stock). The cash dividend is in the amount of $1,352.36 per share of Series G preferred stock (resulting in a distribution of approximately $0.338090 per depositary share) and is payable on December 15, 202...
-
PHINIA Board Declares Quarterly Dividend of $0.30 per Common Share
AUBURN HILLS, Mich.--(BUSINESS WIRE)--PHINIA Inc. (NYSE: PHIN), a diversified industrial supplier and global leader in the development of fuel systems, electrical systems, and aftermarket solutions, today announced that its Board of Directors has declared a quarterly cash dividend in the amount of $0.30 per common share, payable on December 11, 2026, to shareholders of record at the close of business on November 23, 2026. About PHINIA PHINIA is a diversified industrial supplier and global leade...
-
VF Corporation Announces Participation at J.P. Morgan’s 8th Annual Global Luxury & Brands Conference
DENVER--(BUSINESS WIRE)--VF Corporation Announces Participation At J.P. Morgan’s 8th Annual Global Luxury & Brands Conference...
-
MVB Financial Corp. to Attend the TD Cowen 2026 Financials & Fintech Conference
FAIRMONT, W.Va.--(BUSINESS WIRE)--MVB to attend TD Cowen conference in NY next week....
-
ExxonMobil Advances Next Phase of Guyana Development with Longtail
SPRING, Texas--(BUSINESS WIRE)--ExxonMobil advances the Longtail development offshore Guyana, adding future production capacity and supporting economic growth....
-
Almonty Industries Reports Third Quarter 2026 Financial Results
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (Nasdaq: ALM; Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced its financial results for the three and nine months ended September 30, 2026. All figures are presented in Canadian dollars unless otherwise noted. Financial Summary: Three Months Ended September 30, Nine Months Ended September 30, (in thousands of Canadian dollars, except per share amounts) 2026 2025 2026 2025...
-
Veradermics to Present at the Jefferies Global Healthcare Conference in London
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that company management will present at the Jefferies Global Healthcare Conference in London on Thursday, November 19, 2026, at 8:30 a.m. GMT / 3:30 a.m. EST. A live webcast of the presentation will be available on the “Events” page of the “Investors” section of the Company’s...
-
Advanced Drainage Systems Closes Acquisition of StormTrap Investments LLC From PSP Capital
HILLIARD, Ohio--(BUSINESS WIRE)--Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading provider of innovative water management solutions in the stormwater and onsite wastewater industries today announced that it has completed the previously disclosed acquisition of StormTrap Investments LLC (“StormTrap”), an industry leader in large volume, space-constrained, highly engineered stormwater solutions. This transaction expands ADS’ addressable market with a complementary o...
-
UBS Announces Redemption of Ten ETNs
NEW YORK--(BUSINESS WIRE)--UBS AG announced today that it will redeem all of the outstanding securities in each of the ten series of UBS-issued exchange traded notes set forth in the following table (collectively, the “ETNs”), which are currently listed on NYSE Arca. UBS AG expects to deliver redemption notices with respect to each of the ETNs to holders of the applicable ETNs with Call Settlement Dates as set forth in the table below. With respect to BDCZ, this press release is an advance anno...
-
DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (“DiaMedica” or the “Company”) (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), today provided a business update and reported financial results for the third quarter ended September 30, 2026. Management will host a conference call Friday, November 13, 2026, at 8:00 AM Eastern Time / 7:00 AM Central Time...